Asia Bioscience

Asia Bioscience is a biopharmaceutical company based in Thailand that operates as the marketing and distribution arm of the Siam Bioscience Group. The company focuses on the commercialization of high-quality biosimilars and recombinant proteins to improve healthcare accessibility in Southeast Asia. Its primary products include Hemax (epoetin alfa) for anemia and Myelogen (filgrastim) for neutropenia, both produced using advanced manufacturing standards. Asia Bioscience plays a pivotal role in the regional biopharmaceutical supply chain, bridging the gap between complex drug development and patient delivery. The company continues to expand its portfolio through partnerships and the introduction of new monoclonal antibody biosimilars. It was established as a joint venture to leverage regional expertise in both finance and biotechnology.